Crinetics Pharmaceuticals (CRNX) Revenue & Revenue Breakdown
Crinetics Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$1.04M
Latest Revenue (Q)
$361.00K
Crinetics Pharmaceuticals Revenue by Period
Crinetics Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $1.04M | -74.11% |
| 2023-12-31 | $4.01M | -15.28% |
| 2022-12-31 | $4.74M | 339.42% |
| 2021-12-31 | $1.08M | 1418.31% |
| 2020-12-31 | $71.00K | -94.05% |
| 2019-12-31 | $1.19M | -50.86% |
| 2018-12-31 | $2.43M | 18.73% |
| 2017-12-31 | $2.04M | 247.20% |
| 2016-12-31 | $589.00K | - |
Crinetics Pharmaceuticals generated $1.04M in revenue during NA 2024, up -74.11% compared to the previous quarter, and up 87.09% compared to the same period a year ago.
Crinetics Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $361.00K | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | -100.00% |
| 2024-06-30 | $399.00K | -37.66% |
| 2024-03-31 | $640.00K | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2023-09-30 | $346.00K | -64.98% |
| 2023-06-30 | $988.00K | -63.12% |
| 2023-03-31 | $2.68M | 277.86% |
| 2022-12-31 | $709.00K | 54.80% |
| 2022-09-30 | $458.00K | 4.33% |
| 2022-06-30 | $439.00K | -85.98% |
| 2022-03-31 | $3.13M | 190.45% |
| 2021-12-31 | $1.08M | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | -100.00% |
| 2020-03-31 | $71.00K | -77.88% |
| 2019-12-31 | $321.00K | -36.44% |
| 2019-09-30 | $505.00K | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $367.00K | -53.01% |
| 2018-12-31 | $781.00K | 42.52% |
| 2018-09-30 | $548.00K | -16.59% |
| 2018-06-30 | $657.00K | 48.64% |
| 2018-03-31 | $442.00K | -16.29% |
| 2017-12-31 | $528.00K | -17.50% |
| 2017-09-30 | $640.00K | -23.08% |
| 2017-06-30 | $832.00K | 1748.89% |
| 2017-03-31 | $45.00K | - |
Crinetics Pharmaceuticals generated $361.00K in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Crinetics Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ANAB | AnaptysBio | $91.28M | $27.77M |
| YMAB | Y-mAbs Therapeutics | $87.69M | $20.90M |
| STRO | Sutro Biopharma | $62.04M | $17.40M |
| MGTX | MeiraGTx | $33.28M | $1.93M |
| IDYA | IDEAYA Biosciences | $7.00M | - |
| KROS | Keros Therapeutics | $3.55M | $211.25M |
| QTTB | Q32 Bio | $1.16M | - |
| CRNX | Crinetics Pharmaceuticals | $1.04M | $361.00K |
| REPL | Replimune Group | - | - |
| SRRK | Scholar Rock | - | - |